Step One: Wide-moat stocks with 5-star and 4-star ratings

Historical evidence says that, while quality alone is a poor indicator of outperformance, when combined with a decent valuation filter, Morningstar’s moat rating proves to be more than useful. Based on the available data, stocks with a wide-moat rating that also fit into the 4- or 5-star category deserve to be the subject of further analysis. See the detailed explanation and the underlying evidence of our first step in this article.

We focus on those companies that are covered by a Morningstar analyst as assigning a wide-moat rating without thorough analysis is a questionable practice in our opinion. As of August 28, there were 180 wide-moat stocks meeting our criteria.

Only 5.6% (10 stocks) of this wide-moat group earned a 5-star (most attractive) valuation rating. Here are they:

We believe that the percentage of 5-star-rated wide-moat stocks is a good indicator of market sentiment. When this percentage is high, even the best companies are on sale. When the percentage is extremely low, market conditions may warrant caution. (Please note that this is not an indicator for market timing!)

As these best of breed companies may be worth a closer look even when they are just slightly cheaper than their fair value but are not in the bargain bin, we also list the 4-star-rated wide-moat stocks as of August 28:

Company Name Ticker
Altria Group Inc. MO
Anheuser-Busch InBev SA/NV BUD
Biogen Inc. BIIB
Boeing Co. BA
Charles Schwab Corp. SCHW
Coca-Cola Co. KO
Compass Minerals International Inc. CMP
Constellation Brands Inc. STZ
Enbridge Inc. ENB
General Dynamics Corp. GD
Gilead Sciences Inc. GILD
Grupo Aeroportuario del Sureste SAB de CV ASR
Intel Corp. INTC
John Wiley & Sons Inc. JW.A
Julius Baer Gruppe AG OTCPK:JBAXY
Kellogg Co. K
Magellan Midstream Partners LP MMP
Merck & Co Inc. MRK
Pfizer Inc. PFE
Philip Morris International Inc. PM
Raytheon Technologies Corp. RTX
Roche Holding AG OTCQX:RHHBY
Sanofi SA SNY
The Toronto-Dominion Bank TD
U.S. Bancorp USB
Westpac Banking Corp. WBK
Zimmer Biomet Holdings Inc. ZBH
READ ALSO  CaixaBank and Bankia agree terms to create Spain’s biggest lender

All in all, we have 37 firms that pass our very first criteria. (Down from 47 a month ago.)

Step Two: Historical Valuation in the EVA Framework

We believe that the most widely used valuation multiples are terribly flawed. See this article on why we consider the Future Growth Reliance metric the best-of-breed sentiment indicator that addresses accounting distortions, thus gives us a true picture of which wide-moat companies seem attractively valued in historical terms. We want to buy our top-quality targets when the baked-in expectations are low, since that is when surprising on the upside has the highest probability. As investment is a game of probabilities, all we can do is stack the odds in our favor as much as possible.

23 of the 37 stocks survived this second step. Here’s the list:

Company Name Ticker
Altria Group Inc. MO
Ambev SA ABEV
Bayer AG OTCPK:BAYRY
Biogen Inc. BIIB
British American Tobacco PLC BTI
Charles Schwab Corp. SCHW
Compass Minerals International Inc. CMP
Core Laboratories NV CLB
Enbridge Inc. ENB
Enterprise Products Partners LP EPD
Julius Baer Gruppe AG OTCPK:JBAXY
General Dynamics Corp. GD
Grupo Aeroportuario del Sureste SAB de CV ASR
Imperial Brands PLC OTCQX:IMBBY
Intel Corp. INTC
John Wiley & Sons Inc. JW.A
Kellogg Co. K
Magellan Midstream Partners LP MMP
Merck & Co. Inc. MRK
Philip Morris International Inc. PM
The Toronto-Dominion Bank TD
U.S. Bancorp USB
Wells Fargo & Co. WFC

We are rather strict when it comes to historical valuation. There are stocks that unquestionably fail both or short- and long-term tests like Pfizer (PFE):

READ ALSO  JPMorgan Warns Of $200 BIllion In Forced Month-End Selling

Source: evaexpress.com

There are some targets, however, that may look attractively valued if you only focus on the short term (like the last 5 years), but the longer you zoom out, the more you lose your appetite. It comes down to personal preference where you draw the line. For us, only those stocks are allowed to appear on the heat map in our third step that seem attractively valued in both a short-term and long-term context. (We go back as far as 20 years, calculate averages and medians on different time frames and let our algorithm do the ruthless work.)

Step Three: The Heat Map of the Most Investable Wide-Moat Stocks

Seeing the stocks of our shortlist on a heat map with a quality and valuation axis is something that can prove very useful when we need to make a decision on which candidates to analyze thoroughly. As explained in our previous article, we use the PRVit (Performance-Risk-Valuation investment technology) model of the EVA Dimensions team.

All in all, PRVit is a multifactor quantitative stock selection model based on EVA-centric measures of Performance, Risk, and Valuation. It first estimates the fundamental value of a company based on its risk-adjusted EVA performance (shown on the vertical axis) and then compares it to its actual valuation (shown on the horizontal axis). All factors in this model were chosen heuristically based on common sense, and not by data mining, yet strong and statistically significant backtests prove the soundness of the PRVit approach both in the U.S. and globally. (See the details here.)

READ ALSO  SE: Neste CEO on EU Emissions, Renewable Energy, Green Bonds

Here is the heat map as of August 28:

Source: evaexpress.com

We also present the results in a table format to make your decision easier.

Source: evaexpress.com, Morningstar

(Stocks highlighted in light blue are Morningstar’s 5-star-rated wide-moat names that survived the second step of our process.)

In PRVit, the factors are grouped into three categories: Performance, Risk, and Valuation. Each company has a composite 0-100 score in each category, where higher is better for Performance and lower is better for Risk and Valuation. We believe that stocks in the upper quintile of the PRVit ranking (with a PRVit score above 80) are worth a closer look.

We plan to run this three-step process on a monthly basis and publish the shortlist of targets it produces. Also, the members of the FALCON Team are publishing thorough analyses of the most promising targets. If you don’t want to miss any of these pieces, please scroll up and click “Follow”.

Disclosure: I am/we are long MO KO ENB GILD PM RTX WFC. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.



Via SeekingAlpha.com